Tokenvizz: GraphRAG-Inspired Tokenization Tool for Genomic Data Discovery and Visualization is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2024). On theSindex it has a DataRank of 0.104. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.104
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 3UL1TR002548-03S1
Clinical and Translational Science Collaborative of Cleveland
National Institutes of Health
Grant: 5R01AG057557-05
An Integrated Reverse Engineering Approach Toward Rapid drug Re positioning for Alzheimer's Disease
National Institutes of Health
Grant: 5R56AG062272-02
Construct large-scale phenomes of disease and drugs and develop data-driven systems approaches to understand genetic links between Alzheimer's disease and Neuropsychiatric symptoms
National Institutes of Health
Grant: 5R01AA029831-02
Characterize multifaceted interactions between COVID-19 and alcohol use disorder based on real-time analysis of electronic health records of 62 million adult patients
National Institutes of Health
Grant: 5UG1DA049435-05
Greater Southern California Node of the Clinical Trials Network
National Institutes of Health
Grant: 1Z01DA000114-02
RECEPTOR CDNA EXPRESSION CLONING USING LIGAND AUTORADIOGRAPHIC SCREENING
National Institutes of Health
Grant: 5R01AG061388-02
Combine computational prediction, network analysis and genetic screening in C elegans to uncover neurodegenerative causes in Alzheimer's Disease
National Institutes of Health
Grant: 5R01EY029297-03
Repositioning of Clinically Approved Drugs toward the Prevention and Risk Evaluation of Early Cataract Progression
Fields of Study
Keywords